logo
episode-header-image
Jan 2025
2m 32s

U.S. Indexes Trim Gains After Strong Wee...

The Wall Street Journal
About this episode

Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports.


Sign up for the WSJ's free What's News newsletter. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Up next
Yesterday
Nasdaq Rises to New Record as President Trump Sends More Tariff Letters
Plus: Drugmaker Merck strikes a roughly $10 billion deal to buy Verona Pharma. The Justice Department’s criminal healthcare-fraud unit investigates UnitedHealth’s Medicare billing practices. And, shares in advertising conglomerate WPP tumble after it said clients were pulling bac ... Show More
2m 38s
Yesterday
Trump Administration Goes After Harvard’s Accreditation
Plus, Linda Yaccarino steps down as CEO of X after two years on the job. And U.S. measles cases hit a 33-year high. Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices 
2m 41s
Yesterday
Trump Losing Patience With Putin Over Ukraine
Plus: The U.S. seeks to ban China from buying American farmland. And a key architect of Apple’s supply chain will step down later this month. Luke Vargas hosts. Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices 
2m 53s
Recommended Episodes
Oct 2024
What’s News in Markets: United Soars, CVS Warns, Netflix Shines
How did rivals help United take off? And what has investors worried about the health of CVS? Plus, why Netflix shares jumped. Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Lea ... Show More
5m 27s
Apr 19
What’s News in Markets: Lilly Surges, UnitedHealth Plummets, Netflix Aims for $1 Trillion
Why did news from a weight-loss drug pill trial boost Eli Lilly? And how are costs in the Medicare business affecting UnitedHealth? Plus, what ambitious goals has Netflix set for itself? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove ... Show More
5m 13s
Aug 2024
A Blip or a Trend? Making Sense of Monday’s Stock Selloff
A.M. Edition for August 6. U.S. stock futures rise and Japan’s Nikkei has climbs 10% after yesterday’s market freak-out. WSJ Heard on the Street columnist Jon Sindreu explains how Monday’s rout may have been exaggerated by trend chasers. Plus, WSJ tech reporter Sam Schechner look ... Show More
11m 38s
Feb 2025
What’s News in Markets: Tariff Trade, Robinhood’s Crypto Gains, Unilever Slides
How is Coca-Cola dealing with aluminum tariffs? And how are crypto’s gains benefiting Robinhood? Plus, why Unilever shares dropped. Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Le ... Show More
5m 24s
Jan 2025
What’s News in Markets: Banking Boom, Macy’s Troubles, Drugmakers Slide
What’s driving big banks’ profit gains? And what was the result of the holiday season at Macy’s? Plus, what drove drops in some drugmakers’ shares? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Market ... Show More
6m 3s
Aug 2024
What’s News in Markets: Buffett on Apple, Airbnb Slowdown, Weight-Loss Battles
What happened to Apple stock after Warren Buffett sold it? And why wasn’t Airbnb fully booked? Plus, who’s winning the weight-loss drug race? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Learn more about your ad choices. Visit ... Show More
13m 15s
Oct 2024
The Magnificent Seven Aren’t This Market’s Only Winners
P.M. Edition for Oct. 8. WSJ markets reporter Hardika Singh discusses whether the third quarter earnings reports can show there’s more to the S&P 500 than just the Magnificent Seven. And WSJ’s Jared Hopkins explains what’s next for Pfizer after an activist investor revealed a $1 ... Show More
13m 25s
Jul 2024
What’s News in Markets: Magnificent Seven, Spotify Jumps, UPS Disappoints
What made the Magnificent Seven so miserable? And why did Spotify’s latest earnings call please investors? Plus, how UPS failed to deliver. Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Learn more about your ad choices. Visit m ... Show More
5m 36s
May 21
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica ... Show More
20m 12s
Listen to millions of songs and podcasts on Anghami